Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Miller, V; Vandamme, AM; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait-Khaled, M; Boucher, C; Brun-Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; Broekhuizen, A; Bush-Donovan, C; Camacho, R; Carlier, H; Clavel, F; Clotet, B; Clumeck, N; Colebunders, R; De Clerq, K; De Jaegher, JJ; De Schrijver, G; De Smet, K; Hall, W; Harrigan, R; Hatzakis, A; Hellmann, N; Hoetelmans, R; Holtzer, C; Katlama, C; Larder, D; Loriaux, E; McCreedy, B; Mulcahy, F; Opravil, M; Phillips, A; Ruiz, N; Shulse, E; Sonnerborg, A; Soriano, V; Steel, H; Vella, S; Williams, A
   Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
   AIDS
   
   V. Miller et al., "Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting", AIDS, 15(3), 2001, pp. 309-320
2. DeGruttola, V; Dix, L; D'Aquila, R; Holder, D; Phillips, A; Ait-Khaled, M; Baxter, J; Clevenbergh, P; Hammer, S; Harrigan, R; Katzenstein, D; Lanier, R; Miller, M; Para, M; Yerly, S; Zolopa, A; Murray, J; Patick, A; Miller, V; Castillo, S; Pedneault, L; Mellors, J
   The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan
   ANTIVIRAL THERAPY
   
   V. DeGruttola et al., "The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan", ANTIVIR TH, 5(1), 2000, pp. 41-48
3. Tisdale, M; Myers, R; Randall, S; Maguire, M; Ait-Khaled, M; Elston, R; Snowden, W
   Resistance to the HIV protease inhibitor amprenavir in vitro and in clinical studies - A review
   CLINICAL DRUG INVESTIGATION
   
   M. Tisdale et al., "Resistance to the HIV protease inhibitor amprenavir in vitro and in clinical studies - A review", CLIN DRUG I, 20(4), 2000, pp. 267-285
4. Katlama, C; Clotet, B; Plettenberg, A; Jost, J; Arasteh, K; Bernasconi, E; Jeantils, V; Cutrell, A; Stone, C; Ait-Khaled, M; Purdon, S
   The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial
   AIDS
   
   C. Katlama et al., "The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial", AIDS, 14(7), 2000, pp. 781-789
5. Miller, V; Ait-Khaled, M; Stone, C; Griffin, P; Mesogiti, D; Cutrell, A; Harrigan, R; Staszewski, S; Katlama, C; Pearce, G; Tisdale, M
   HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy
   AIDS
   
   V. Miller et al., "HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy", AIDS, 14(2), 2000, pp. 163-171
6. Rakik, A; Ait-Khaled, M; Griffin, P; Thomas, DA; Tisdale, M; Kleim, JP
   A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   A. Rakik et al., "A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors", J ACQ IMM D, 22(2), 1999, pp. 139-145
7. Griffiths, PD; Ait-Khaled, M; Bearcroft, CP; Clark, DA; Quaglia, A; Davies, SE; Burroughs, AK; Rolles, K; Kidd, IM; Knight, SN; Noibi, SM; Cope, AV; Phillips, AN; Emery, VC
   Human herpesviruses 6 and 7 as potential pathogens after liver transplant:Prospective comparison with the effect of cytomegalovirus
   JOURNAL OF MEDICAL VIROLOGY
   
   P.D. Griffiths et al., "Human herpesviruses 6 and 7 as potential pathogens after liver transplant:Prospective comparison with the effect of cytomegalovirus", J MED VIROL, 59(4), 1999, pp. 496-501
8. Clarke, JR; Braganza, R; Mirza, A; Stainsby, C; Ait-Khaled, M; Wright, A; Lyall, H; Parker, D; McClure, MO; Weber, JN; Taylor, GP
   Rapid development of genotypic resistance to lamivudine when combined withzidovudine in pregnancy
   JOURNAL OF MEDICAL VIROLOGY
   
   J.R. Clarke et al., "Rapid development of genotypic resistance to lamivudine when combined withzidovudine in pregnancy", J MED VIROL, 59(3), 1999, pp. 364-368